mRNA |
cyanoquinoline 11 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.008 |
mRNA |
CGP-082996 |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
0.009 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
AEW541 |
CCLE |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
AT-7519 |
GDSC1000 |
pan-cancer |
AAC |
0.08 |
0.01 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.01 |
mRNA |
TKI258 |
CCLE |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.01 |
mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |
mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.01 |